Bio-Gene Technology receives $343,000 R&D tax incentive

Bio-Gene Technology Limited (ASX:BGT) has received a $343,000 research and development tax incentive (RDTI) from the Australian Taxation Office. The funds relate to eligible R&D expenditure incurred during the 2026 financial year.

The Australian company focuses on developing nature-derived bio-insecticides to combat insecticide resistance and meet the demand for natural pest control. The incentive, which provides cash equivalent to 43.5% of qualifying expenditure, will support the development of the company’s flagship products, Flavocide® and Qcide®.

Managing Director and CEO Tim Grogan stated that the federal government initiative materially assists the company in undertaking technical activities required to develop products for global markets.